TBI TrueBlue, Inc.

NYSE trueblue.com


$ 4.51 $ -0.07 (-1.53 %)    

Thursday, 20-Nov-2025 15:59:54 EST
QQQ $ 584.62 $ -14.20 (-2.37 %)
DIA $ 458.30 $ -3.66 (-0.79 %)
SPY $ 652.19 $ -10.10 (-1.52 %)
TLT $ 89.30 $ 0.35 (0.39 %)
GLD $ 375.00 $ -0.11 (-0.03 %)
$ 4.5
$ 4.61
$ 4.48 x 300
$ 4.51 x 116
$ 4.47 - $ 4.69
$ 3.45 - $ 9.05
132,408
na
134.73M
$ 1.12
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-03-2025 09-28-2025 10-Q
2 08-04-2025 06-29-2025 10-Q
3 05-05-2025 03-30-2025 10-Q
4 02-19-2025 12-29-2024 10-K
5 11-04-2024 09-29-2024 10-Q
6 08-05-2024 06-30-2024 10-Q
7 05-06-2024 03-31-2024 10-Q
8 02-21-2024 12-31-2023 10-K
9 10-23-2023 09-24-2023 10-Q
10 07-24-2023 06-25-2023 10-Q
11 04-24-2023 03-26-2023 10-Q
12 02-15-2023 12-25-2022 10-K
13 10-24-2022 09-25-2022 10-Q
14 07-25-2022 06-26-2022 10-Q
15 04-25-2022 03-27-2022 10-Q
16 02-16-2022 12-26-2021 10-K
17 10-25-2021 09-26-2021 10-Q
18 07-26-2021 06-27-2021 10-Q
19 04-26-2021 03-28-2021 10-Q
20 02-22-2021 12-27-2020 10-K
21 10-26-2020 09-27-2020 10-Q
22 07-27-2020 06-28-2020 10-Q
23 05-04-2020 03-29-2020 10-Q
24 02-24-2020 12-29-2019 10-K
25 10-28-2019 09-29-2019 10-Q
26 07-30-2019 06-30-2019 10-Q
27 04-29-2019 03-31-2019 10-Q
28 02-22-2019 12-30-2018 10-K
29 11-05-2018 09-30-2018 10-Q
30 07-30-2018 07-01-2018 10-Q
31 04-30-2018 04-01-2018 10-Q
32 02-26-2018 12-31-2017 10-K
33 10-30-2017 10-01-2017 10-Q
34 07-31-2017 07-02-2017 10-Q
35 05-01-2017 04-02-2017 10-Q
36 02-24-2017 01-01-2017 10-K
37 10-24-2016 09-23-2016 10-Q
38 07-25-2016 06-24-2016 10-Q
39 04-25-2016 03-25-2016 10-Q
40 02-22-2016 12-25-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 bmo-capital-maintains-outperform-on-trueblue-lowers-price-target-to-6

BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and lowers the price target from $8 to $6.

 trueblue-sees-q4-sales-399000m-424000m-vs-410873m-est

TrueBlue (NYSE:TBI) sees Q4 sales of $399.000 million-$424.000 million vs $410.873 million analyst estimate.

 trueblue-q3-adj-eps-003-beats-008-estimate-sales-431266m-beat-409007m-estimate

TrueBlue (NYSE:TBI) reported quarterly earnings of $0.03 per share which beat the analyst consensus estimate of $(0.08) by 136....

 bmo-capital-maintains-outperform-on-trueblue-raises-price-target-to-8

BMO Capital analyst Jeffrey Silber maintains TrueBlue (NYSE:TBI) with a Outperform and raises the price target from $7 to $8.

 trueblue-sees-q3-sales-400000m-425000m-vs-393204m-est

TrueBlue (NYSE:TBI) sees Q3 sales of $400.000 million-$425.000 million vs $393.204 million analyst estimate.

 trueblue-q2-adj-eps-007-beats-010-estimate-sales-396299m-miss-400530m-estimate

TrueBlue (NYSE:TBI) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.10) by 28.5...

Core News & Articles

The Rights Agreement is intended to reduce the likelihood that any entity, person or group is able to gain control of TrueBlue ...

 trueblue-board-unanimously-rejects-hirequests-750shr-all-stock-acquisition-proposal

Proposal Significantly Undervalues the Company and Is Not in the Best Interest of ShareholdersShareholders Do Not Need to Take ...

Core News & Articles

Offers a Significant Premium of 61% to TrueBlue StockholdersHireQuest's High-Margin Franchising Model to drive near-term pr...

 trueblue-sees-q2-sales-392000m-417000m-vs-38018m-est

TrueBlue (NYSE:TBI) sees Q2 sales of $392.000 million-$417.000 million vs $380.18 million analyst estimate.

 trueblue-q1-adj-eps-040-misses-032-estimate-sales-37025m-beat-36227m-estimate

TrueBlue (NYSE:TBI) reported quarterly losses of $(0.40) per share which missed the analyst consensus estimate of $(0.32) by 25...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION